Skip to main content

Table 3 Evolution of the monthly average cost of antiasthmatic drugs compared to guaranteed minimum wage moroccan asthma

From: Trends in the use of antiasthmatic medications in Morocco (1999–2010)

  1999 2006 2010
AME AME/GMW NS NP AME AME/GMW NS NP AME AME/GMW NS NP
Short-acting inhaled Beta-2-mimetic 66.5 4.01 7 9 77.5 3.86 9 11 38.61 1.83 8 12
Long-acting inhaled Beta-2-mimetic 425.5 25.64 2 3 265.04 13.19 3 4 209.17 9.92 2 2
Systemic Beta-2-mimetic 76.4 4.60 4 14 68.61 3.41 7 18 71.27 3.38 6 13
Inhaled Glucocorticosteroids alone 192.9 11.82 5 9 147.06 7.32 8 15 144.66 6.86 11 15
Association Beta-2-mimetic /Glucocorticosteroids - - - - 363.02 18.07 2 6 209.20 9.92 4 13
Injectable Xanthines 46.1 2.77 9 22 54.73 2.72 9 18 56.07 2.67 5 13
  (161.40 ± 158.32) (9.77 ± 9.55) 27 57 (162.66 ± 125.39) (8.10 ± 6,24) 38 72 (121.5 ± 76.93) (5.76 ± 3.65) 36 68
  1. AME : Average Monthly Expenditure (MAD).
  2. GMW : Guaranteed Minimum Wage (MAD) (High Commission of Planning-HCP 2010).
  3. AME/GMW : In percentage.
  4. NS : Number of Specialties / NP : Number of Pharmaceutical Presentations.
  5. 1999 : GMW = 150.89 € AME/GMW = 9.72% CI = [2.12% ; 21.56%] with 95%.
  6. 2006 : GMW = 182.66 € AME/GMW = 8.10% CI = [1.54% ; 14.65%] with 95%.
  7. 2010 : GMW = 191.74 € AME/GMW = 5.76% CI = [1.94% ; 9.59%] with 95%.